Current Neurology and Neuroscience Reports

, Volume 9, Issue 6, pp 430–434 | Cite as

Neurologic manifestations of varicella zoster virus infections

Article

Abstract

Varicella zoster virus (VZV) causes acute viral exanthema in childhood, becomes latent, and can reactivate years later to produce neurologic disease. Primary VZV infection is associated with acute cerebellitis and stroke, particularly in childhood. VZV reactivation may result in neuropathy, myelitis, stroke, and encephalitis, the latter two syndromes the result of small and large vessel vasculopathy. Prompt diagnosis and treatment are critical to minimize morbidity in herpes zoster as well as morbidity and death in VZV vasculitis and encephalitis. Detection of anti-VZV antibodies in cerebrospinal fluid is the most sensitive method of diagnosing varicella infection of the nervous system. Despite the advent of the VZV vaccine, varicella remains a significant cause of neurologic morbidity.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References and Recommended Reading

  1. 1.
    Whitley RJ: Varicella-zoster virus. In Principles and Practice of Infectious Diseases. Edited by Mandell GL, Bennett JE, Dolin R. New York: Churchill-Livingston; 1995:1345–1351.Google Scholar
  2. 2.
    Mahalingam R, Wellish M, Wolf W, et al.: Latent varicellazoster viral DNA in human trigeminal and thoracic ganglia. N Engl J Med 1990, 323:627–631.PubMedGoogle Scholar
  3. 3.
    Baadsgaard O, Lindskov R, Geisler C: Reduction of the number of immunocompetent cells in the acute stage of herpes zoster. Arch Dermatol Res 1987, 279:374–378.CrossRefPubMedGoogle Scholar
  4. 4.
    Hope-Simpson RE: The nature of herpes zoster: a longterm study and a new hypothesis. Proc R Soc Med 1965, 58:9–20.PubMedGoogle Scholar
  5. 5.
    Watson CP, Deck JH, Morshead C, et al.: Post-herpetic neuralgia: further post-mortem studies of cases with and without pain. Pain 1991, 44:105–117.CrossRefPubMedGoogle Scholar
  6. 6.
    Gilden DH, Wright RR, Schneck SA, et al.: Zoster sine herpete, a clinical variant. Ann Neurol 1994, 35:530–533.CrossRefPubMedGoogle Scholar
  7. 7.
    Gilden DH, Gesser R, Smith J, et al.: Presence of VZV and HSV-1 DNA in human nodose and celiac ganglia. Virus Genes 2001, 23:145–147.CrossRefPubMedGoogle Scholar
  8. 8.
    Linnemann CC Jr, Alvira MM: Pathogenesis of varicellazoster angiitis in the CNS. Arch Neurol 1980, 37:239–240.PubMedGoogle Scholar
  9. 9.
    Rosenblum WI, Hadfield MG, Young HF: Granulomatous angiitis with preceding varicella zoster. Ann Neurol 1978, 3:374–375.CrossRefPubMedGoogle Scholar
  10. 10.
    Devinsky O, Cho ES, Petito CK, Price RW: Herpes zoster myelitis. Brain 1991, 114:1181–1196.CrossRefPubMedGoogle Scholar
  11. 11.
    Gilden DH, Mahalingam R, Cohrs RJ, et al.: The protean manifestations of varicella-zoster virus vasculopathy. J Neurovirol 2002, 8(Suppl 2):75–79.CrossRefPubMedGoogle Scholar
  12. 12.
    Weller TH: Varicella-herpes zoster virus. In Viral Infections of Humans: Epidemiology and Control. Edited by Evans AS. New York: Plenium; 1989:659–683.Google Scholar
  13. 13.
    Dangond F, Engle E, Yessayan L, Sawyer MH: Pre-eruptive varicella cerebellitis confirmed by PCR. Pediatr Neurol 1993, 9:491–493.CrossRefPubMedGoogle Scholar
  14. 14.
    Johnson R, Milbourn PE: Central nervous system manifestations of chickenpox. Can Med Assoc J 1970, 102:831–834.PubMedGoogle Scholar
  15. 15.
    Donahue JG, Choo PW, Manson JE, Platt R: The incidence of herpes zoster. Arch Intern Med 1995, 155:1605–1609.CrossRefPubMedGoogle Scholar
  16. 16.
    Gilden DH, Hayward AR, Krupp J, et al.: Varicella-zoster virus infection of human mononuclear cells. Virus Res 1987, 7:117–129.CrossRefPubMedGoogle Scholar
  17. 17.
    Ozaki T, Ichikawa T, Matsui Y, et al.: Viremic phase in nonimmunocompromised children with varicella. J Pediatr 1984, 104:85–87.CrossRefPubMedGoogle Scholar
  18. 18.
    Nagel MA, Cohrs RJ, Mahalingam R, et al.: The varicella zoster virus vasculopathies: clinical, CSF, imaging, and virologic features. Neurology 2008, 70:853–860.CrossRefPubMedGoogle Scholar
  19. 19.
    Portenoy RK, Duma C, Foley KM: Acute herpetic and postherpetic neuralgia: clinical review and current management. Ann Neurol 1986, 20:651–664.CrossRefPubMedGoogle Scholar
  20. 20.
    Gauthier A, Breuer J, Carrington D, et al.: Epidemiology and cost of herpes zoster and post-herpetic neuralgia in the United Kingdom. Epidemiol Infect 2009, 137:38–47.CrossRefPubMedGoogle Scholar
  21. 21.
    Ragozzino MW, Melton LJ 3rd, Kurland LT, et al.: Population-based study of herpes zoster and its sequelae. Medicine (Baltimore) 1982, 61:310–316.Google Scholar
  22. 22.
    Gilden DH: Herpes zoster with postherpetic neuralgia-persisting pain and frustration. N Engl J Med 1994, 330:932–934.CrossRefPubMedGoogle Scholar
  23. 23.
    Quan D, Hammack BN, Kittelson J, Gilden DH: Improvement of postherpetic neuralgia after treatment with intravenous acyclovir followed by oral valacyclovir. Arch Neurol 2006, 63:940–942.CrossRefPubMedGoogle Scholar
  24. 24.
    Thomas JE, Howard FM Jr: Segmental zoster paresis-a disease profile. Neurology 1972, 22:459–466.PubMedGoogle Scholar
  25. 25.
    Kertes PJ, Baker JD, Noel LP: Neuro-ophthalmic complications of acute varicella. Can J Ophthalmol 1998, 33:324–328.PubMedGoogle Scholar
  26. 26.
    Lee CC, Venketasubramanian N, Lam MS: Optic neuritis: a rare complication of primary varicella infection. Clin Infect Dis 1997, 24:515–516.PubMedGoogle Scholar
  27. 27.
    Gilden DH, Beinlich BR, Rubinstien EM, et al.: Varicellazoster virus myelitis: an expanding spectrum. Neurology 1994, 44:1818–1823.PubMedGoogle Scholar
  28. 28.
    Horten B, Price RW, Jimenez D: Multifocal varicella-zoster virus leukoencephalitis temporally remote from herpes zoster. Ann Neurol 1981, 9:251–266.CrossRefPubMedGoogle Scholar
  29. 29.
    Morgello S, Block GA, Price RW, Petito CK: Varicella-zoster virus leukoencephalitis and cerebral vasculopathy. Arch Pathol Lab Med 1988, 112:173–177.PubMedGoogle Scholar
  30. 30.
    Gray F, Belec L, Lescs MC, et al.: Varicella-zoster virus infection of the central nervous system in the acquired immune deficiency syndrome. Brain 1994, 117:987–999.CrossRefPubMedGoogle Scholar
  31. 31.
    Amlie-Lefond C, Kleinschmidt-Demasters BK, Mahalingam R, et al.: The vasculopathy of varicella-zoster virus encephalitis. Ann Neurol 1995, 37:784–790.CrossRefPubMedGoogle Scholar
  32. 32.
    Askalan R, Laughlin S, Mayank S, et al.: Chickenpox and stroke in childhood: a study of frequency and causation. Stroke 2001, 32:1257–1262.PubMedGoogle Scholar
  33. 33.
    Ganesan V, Kirkham FJ: Mechanisms of ischaemic stroke after chickenpox. Arch Dis Child 1997, 76:522–525.CrossRefPubMedGoogle Scholar
  34. 34.
    Sebire G, Meyer L, Chabrier S: Varicella as a risk factor for cerebral infarction in childhood: a case-control study. Ann Neurol 1999, 45:679–680.CrossRefPubMedGoogle Scholar
  35. 35.
    Schmidbauer M, Budka H, Pilz P, et al.: Presence, distribution and spread of productive varicella zoster virus infection in nervous tissues. Brain 1992, 115:383–398.CrossRefPubMedGoogle Scholar
  36. 36.
    Hilt DC, Buchholz D, Krumholz A, et al.: Herpes zoster ophthalmicus and delayed contralateral hemiparesis caused by cerebral angiitis: diagnosis and management approaches. Ann Neurol 1983, 14:543–553.CrossRefPubMedGoogle Scholar
  37. 37.
    Kuroiwa Y, Furukawa T: Hemispheric infarction after herpes zoster ophthalmicus: computed tomography and angiography. Neurology 1981, 31:1030.PubMedGoogle Scholar
  38. 38.
    Melanson M, Chalk C, Georgevich L, et al.: Varicella-zoster virus DNA in CSF and arteries in delayed contralateral hemiplegia: evidence for viral invasion of cerebral arteries. Neurology 1996, 47:569–570.PubMedGoogle Scholar
  39. 39.
    Lanthier S, Armstrong D, Domi T, deVeber G: Post-varicella arteriopathy of childhood: natural history of vascular stenosis. Neurology 2005, 64:660–663.PubMedGoogle Scholar
  40. 40.
    Miravet E, Danchaivijitr N, Basu H, et al.: Clinical and radiological features of childhood cerebral infarction following varicella zoster virus infection. Dev Med Child Neurol 2007, 49:417–422.CrossRefPubMedGoogle Scholar
  41. 41.
    Nagel MA, Forghani B, Mahalingam R, et al.: The value of detecting anti-VZV IgG antibody in CSF to diagnose VZV vasculopathy. Neurology 2007, 68:1069–1073.CrossRefPubMedGoogle Scholar
  42. 42.
    American Academy of Pediatrics Committee on Infectious Diseases: Prevention of varicella: recommendations for use of varicella vaccines in children, including a recommendation for a routine 2-dose varicella immunization schedule. Pediatrics 2007, 120:221–231.CrossRefGoogle Scholar
  43. 43.
    Oxman MN, Levin MJ, Johnson GR, et al.: A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med 2005, 352:2271–2284.CrossRefPubMedGoogle Scholar
  44. 44.
    Tyring S, Barbarash RA, Nahlik JE, et al.: Famciclovir for the treatment of acute herpes zoster: effects on acute disease and postherpetic neuralgia. A randomized, double-blind, placebo-controlled trial. Collaborative Famciclovir Herpes Zoster Study Group. Ann Intern Med 1995, 123:89–96.PubMedGoogle Scholar
  45. 45.
    Beutner KR, Friedman DJ, Forszpaniak C, et al.: Valaciclovir compared with acyclovir for improved therapy for herpes zoster in immunocompetent adults. Antimicrob Agents Chemother 1995, 39:1546–1553.PubMedGoogle Scholar
  46. 46.
    Madkan VK, Arora A, Babb-Tarbox M, et al.: Open-label study of valacyclovir 1.5 g twice daily for the treatment of uncomplicated herpes zoster in immunocompetent patients 18 years of age or older. J Cutan Med Surg 2007, 11:89–98.PubMedGoogle Scholar
  47. 47.
    Dubinsky RM, Kabbani H, El-Chami Z, et al.: Practice parameter: treatment of postherpetic neuralgia: an evidence-based report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2004, 63:959–965.PubMedGoogle Scholar
  48. 48.
    Shepp DH, Dandliker PS, Meyers JD: Treatment of varicella-zoster virus infection in severely immunocompromised patients. A randomized comparison of acyclovir and vidarabine. N Engl J Med 1986, 314:208–212.PubMedCrossRefGoogle Scholar
  49. 49.
    de Silva SM, Mark AS, Gilden DH, et al.: Zoster myelitis: improvement with antiviral therapy in two cases. Neurology 1996, 47:929–931.PubMedGoogle Scholar
  50. 50.
    Gilden DH, Kleinschmidt-Demasters BK, Laguardia JJ, et al.: Neurologic complications of the reactivation of varicella-zoster virus. N Engl J Med 2000, 342:635–645.CrossRefPubMedGoogle Scholar

Copyright information

© Current Medicine Group, LLC 2009

Authors and Affiliations

  1. 1.Department of NeurologyMedical College of Wisconsin and Children’s Hospital of WisconsinMilwaukeeUSA

Personalised recommendations